Royal Harbor Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Royal Harbor Partners's LLY Position: Q2 2026 in Review
Royal Harbor Partners increased its Eli Lilly (LLY) stake by 2.2% in Q2 2026, buying an estimated $10.2K and bringing the position to 473 shares worth $567K. The position accounts for 0.18% of the portfolio, ranked #38.
Royal Harbor Partners first reported a position in LLY in Q2 2020 and has held it in 22 quarters since. The position peaked at $2.08M in Q2 2022. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Royal Harbor Partners held 473 shares of Eli Lilly worth $567K as of Q2 2026.
- Royal Harbor Partners bought 10 Eli Lilly shares in Q2 2026, an estimated $10.2K.
- Eli Lilly made up 0.18% of Royal Harbor Partners's portfolio in Q2 2026, its #38 holding.
- Royal Harbor Partners first reported a position in Eli Lilly in Q2 2020 and has held it in 22 quarters since.
- Royal Harbor Partners's Eli Lilly position peaked at $2.08M in Q2 2022.
- 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Royal Harbor Partners's 13F filing for Q2 2026, filed 27 Jul 2026.